[Angioplasty in patients already treated with aortocoronary bypass: immediate and short-term results]

A Marzocchi1, G Piovaccari, C Marrozzini

  • 1Istituto di Malattie dell'Apparato Cardiovascolare, Università degli Studi, Bologna.

Cardiologia (Rome, Italy)
|December 1, 1994
PubMed

Insights

Percutaneous transluminal coronary angioplasty (PTCA) in patients with prior bypass grafting shows good immediate results but high restenosis rates. Intracoronary stents may reduce restenosis, particularly in graft bodies.

Area of Science:

  • Cardiovascular Interventions
  • Interventional Cardiology
  • Vascular Surgery

Context:

  • Percutaneous transluminal coronary angioplasty (PTCA) is a procedure for patients with prior aortocoronary bypass grafting (CABG).
  • While PTCA yields good results in native vessels and graft anastomoses, restenosis remains a challenge, especially in graft bodies.
  • Intracoronary stents are increasingly used, potentially improving outcomes and reducing restenosis incidence.

Purpose:

  • To evaluate the number of PTCA procedures performed in CABG patients and their short-term outcomes.
  • To assess the efficacy of PTCA and stent implantation in managing coronary artery disease in patients with prior CABG.

Summary:

  • A 1993 study across 10 Italian centers reported 3,519 PTCA procedures, with 233 (6.6%) in CABG patients.
  • Angiographic and clinical success was achieved in 92% of cases, with major complications in 4.7% including myocardial infarctions and deaths.
  • Stent implantation occurred in 19.3% of cases. Six-month follow-up showed 63.6% asymptomatic patients, but 32.9% experienced angina, necessitating further interventions.

Impact:

  • The study highlights the effectiveness of PTCA in CABG patients, with a significant success rate and manageable complication profile.
  • The data suggests that while PTCA offers immediate benefits, restenosis remains a concern, underscoring the role of intracoronary stents.
  • Long-term follow-up data from Bologna indicates sustained outcomes, providing valuable insights for managing complex coronary artery disease.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...